New Delhi: Zydus Cadila has received US Food and Drug Administration (FDA), the US health regulator's, approval to promote aripiprazole orally disintegrating tablets in the US market.
The drug is used as an anti- psychotic medication for the treatment of schizophrenia.
Cadilla has received tentative permission for the tablets in the strengths of 10 miligrams (MG), 15 (MG), 20 (MG) and 30 (MG), according to a company statement.
No comments:
Post a Comment